These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8562938)

  • 21. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
    Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
    Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
    Neudenberger J; Hotfilder M; Rosemann A; Langebrake C; Reinhardt D; Pieters R; Schrauder A; Schrappe M; Röttgers S; Harbott J; Vormoor J
    Br J Haematol; 2006 May; 133(3):337-44. PubMed ID: 16643437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases.
    Mauvieux L; Delabesse E; Bourquelot P; Radford-Weiss I; Bennaceur A; Flandrin G; Valensi F; MacIntyre EA
    Br J Haematol; 1999 Dec; 107(3):674-6. PubMed ID: 10583275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases.
    Schoch C; Schnittger S; Klaus M; Kern W; Hiddemann W; Haferlach T
    Blood; 2003 Oct; 102(7):2395-402. PubMed ID: 12805060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
    Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
    J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalities.
    Mathew S; Behm F; Dalton J; Raimondi S
    Leukemia; 1999 Nov; 13(11):1713-20. PubMed ID: 10557043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells.
    Tse W; Zhu W; Chen HS; Cohen A
    Blood; 1995 Feb; 85(3):650-6. PubMed ID: 7833468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MLL genomic breakpoint distribution within the breakpoint cluster region in de novo leukemia in children.
    Felix CA; Hosler MR; Slater DJ; Parker RI; Masterson M; Whitlock JA; Rebbeck TR; Nowell PC; Lange BJ
    J Pediatr Hematol Oncol; 1998; 20(4):299-308. PubMed ID: 9703001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of acute myeloid leukemia with MLL rearrangements--no increase in the incidence of coexpression of lymphoid-associated antigens on leukemic blasts.
    Tien HF; Hsiao CH; Tang JL; Tsay W; Hu CH; Kuo YY; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH; Lin KS
    Leukemia; 2000 Jun; 14(6):1025-30. PubMed ID: 10865968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures.
    Butler LH; Slany R; Cui X; Cleary ML; Mason DY
    Blood; 1997 May; 89(9):3361-70. PubMed ID: 9129043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia.
    Holden JT; Geller RB; Farhi DC; Holland HK; Stempora LL; Phillips CN; Bray RA
    Blood; 1995 Jul; 86(1):60-5. PubMed ID: 7540889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines.
    Shibuya N; Taki T; Mugishima H; Chin M; Tsuchida M; Sako M; Kawa K; Ishii E; Miura I; Yanagisawa M; Hayashi Y
    Genes Chromosomes Cancer; 2001 Sep; 32(1):1-10. PubMed ID: 11477655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
    Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
    Pui CH; Chessells JM; Camitta B; Baruchel A; Biondi A; Boyett JM; Carroll A; Eden OB; Evans WE; Gadner H; Harbott J; Harms DO; Harrison CJ; Harrison PL; Heerema N; Janka-Schaub G; Kamps W; Masera G; Pullen J; Raimondi SC; Richards S; Riehm H; Sallan S; Sather H; Shuster J; Silverman LB; Valsecchi MG; Vilmer E; Zhou Y; Gaynon PS; Schrappe M
    Leukemia; 2003 Apr; 17(4):700-6. PubMed ID: 12682627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
    Langer T; Metzler M; Reinhardt D; Viehmann S; Borkhardt A; Reichel M; Stanulla M; Schrappe M; Creutzig U; Ritter J; Leis T; Jacobs U; Harbott J; Beck JD; Rascher W; Repp R
    Genes Chromosomes Cancer; 2003 Apr; 36(4):393-401. PubMed ID: 12619163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.
    Wechsler DS; Engstrom LD; Alexander BM; Motto DG; Roulston D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):26-36. PubMed ID: 12461747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23).
    Taki T; Shibuya N; Taniwaki M; Hanada R; Morishita K; Bessho F; Yanagisawa M; Hayashi Y
    Blood; 1998 Aug; 92(4):1125-30. PubMed ID: 9694699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
    Felix CA; Hosler MR; Winick NJ; Masterson M; Wilson AE; Lange BJ
    Blood; 1995 Jun; 85(11):3250-6. PubMed ID: 7756657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FISH analysis of an AML-M5a with segmental rearrangements involving 11q23-MLL region.
    Reddy KS; Parsons L; Wang S; Mak L; Dighe P; Yu TL
    Cancer Genet Cytogenet; 2000 Apr; 118(1):48-51. PubMed ID: 10731590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia.
    Tse W; Meshinchi S; Alonzo TA; Stirewalt DL; Gerbing RB; Woods WG; Appelbaum FR; Radich JP
    Blood; 2004 Nov; 104(10):3058-63. PubMed ID: 15217837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.